company? Let’s change
that.
Don't see your company?
Create a company profileCareXM is a provider of virtual care and patient engagement solutions for post-acute and nonacute healthcare providers.
Conisus offers medical education programs that enable healthcare professionals to better care for patients with cancer and blood disorders.
Council Capital is a Nashville-based healthcare private equity firm with approximately $300 million of capital under management that utilizes its unique CEO Council business model to attract leading management teams and portfolio companies.
Our Medical Scribe Services allow healthcare providers to focus on their patients while meeting essential technology requirements.
Simplify gives ASCs the freedom to provide great care. Founded in 2003 as CyramedX, Simplify ASC developed its highly rated ASC-specific Digital Patient Chart (EHR/EMR) in an effort to digitize paper charts with minimal disruption to an ASC's existing workflows. Clients include both independent ambulatory surgery centers and multi-facility corporate enterprises. With the launch of an integrated Practice Management (PM) platform in 2019 -- including scheduling, advanced reporting, business intelligence, automated inventory management, and billing -- together with the more recent addition of Revenue Cycle Management (RCM) services, Simplify is the most trusted solution for improving surgery center efficiency and profitability through a combination of technology, services, and operational understanding. Isn't it time to Simplify?
Unnatural Products is a startup pairing AI with chemistry to create treatments for drug targets.
At KBP we are consistently reminded that patient care is the end goal of what we do daily. Our discovery team is highly experienced in identifying new compounds with potential. The close interactions of the discovery and development teams result in a deep pipeline with multiple clinical and pre-clinical compounds. The major organ research group is focused on the maintenance and postponement of disease progression of three primary organ systems – lung, heart, and kidney – and is capable of assessing a drug’s activity and active mechanism in both in vitro and in vivo models. The antimicrobial group, leverages a proprietary microbial bank comprised of 20,000+ clinically-isolated strains, including anaerobic bacteria and fungi, to evaluate internally generated drug candidates effectively. The immunology group conducts research on the roles of T- and B-cells in rheumatoid arthritis, hyperuricemia, idiopathic pulmonary fibrosis, among others. Our laser-focus on these three therapeutic areas provides powerful and unique insights on the underlying physiological and pathological processes that drive disease, opening up new avenues to tackle specific targets. Our researchers use their expertise to locate these new directions and exploit them, resulting in innovative therapies for a wide variety of illnesses.
We enable caregivers, public hospitals, and private health enterprises to create a cohesive network for seamless exchange of patients' medical data and provide patient care through a health information system. Our EHR addresses health information management and telehealth platforms that enhance last-mile connectivity to provide health services in underserved and inaccessible areas.
Daxko powers health and wellness throughout the world. Every day, our team members bring their passion and expertise to help health and wellness facilities operate smoothly and engage their members. Whether it’s supporting a fitness club, a community center, or a local boutique studio, Daxko is there, powering 40% of fitness and wellness facilities nationwide. We’re more than just a tech company; we’re committed partners, empowering wellness organizations to create meaningful, lasting impact in their communities.
Digital Diagnostics is a pioneering AI diagnostics company on a mission to transform the quality, accessibility and affordability of healthcare. Founded and led by Dr. Michael Abramoff, an ophthalmologist, neuroscientist and computer engineer, Digital Diagnostics developed a patented biomarker-based approach to build autonomous algorithms that make clinical decisions without human intervention. Digital Diagnostics and its flagship product IDx-DR, an autonomous AI system FDA-authorized to diagnose diabetic retinopathy and diabetic macular edema, has proven that intelligent diagnostic platforms can be used safely, efficiently and equitably to improve patient outcomes. As it expands into other diagnostic capabilities, Digital Diagnostics has paved the way for automated diagnosis to become a new standard of care that will contribute significantly to democratizing healthcare
Transforming Electrosurgery with technology that improves patient outcome, surgeon efficiency, and healthcare cost-effectiveness.
LifeCare Solutions is a leading provider of quality, integrated home healthcare products and services.
Hop Labs is a research and development lab focused on building state-of-the-art and scalable machine-learning solutions. We work with a diverse array of organizations, from early-stage startups to well-established brands. Some clients want to turn a vision into a real product or scalable business, while others are looking for fresh ideas and strategies in order to leverage cutting-edge technology within their company. Though we can't always speak publicly about the work we've done, you'll find a number of case studies on our website. A few past projects have included fighting cancer through deep learning, accelerating the drug discovery process, and even making computers smart enough to help you find the best-fitting pair of pants. We spend a lot of our time helping teams to identify the risks in their strategies, figure out what concrete steps they can take to drive down those risks, and find the most efficient path toward their next meaningful milestone, whether that's closing some pre-launch sales, scaling up their business, or bringing an innovative product to market. Our team is well versed in the world of applied ML and can help with engineering, research, operations, and strategy. We've learned that there's a fine balance between over-building/over-thinking and implementing/producing something without enough critical thinking. On either side of that balance, you might paint yourself into a corner with some unnecessarily poor tech decisions, and we're here to help navigate those waters
Furnished accommodation on-demand
LifeScience Logistics, founded in 2006, is a third party logistics company committed to offering the highest quality, flexibility, and compliance in Healthcare Supply Chain Solutions. LSL operates out of four cGMP compliant and FDA registered facilities (Atlanta, GA, Baltimore, MD, Indianapolis, IN and DFW Airport, TX) totaling more than 1.35 million SF of fully validated and temperature mapped space. Our facilities allow for Control Room Temperature (CRT) and Cold Chain Capabilities; both refrigerated (2 to 8 C) and frozen (-20 C) storage. LSL is a Board of Pharmacy licensed distributor, VAWD-accredited, cGMP and FDA compliant company. Our can-do attitude, and efficient operations, set us apart from our competition. We pride ourselves on our ability to bring the best technology, quality, and intellectual capital to our clients. LifeScience Logistics can be found on the web at www.lslog.com. To get LifeScience Logistics news direct, visit http://www.lslog.com/News/Recent.aspx.
Omni Bioceutical Innovations is committed to delivering innovative skin treatment.
MEI Pharma is a San Diego-based clinical-stage pharmaceutical company committed to the development and commercialization of novel, best-in-class, cancer therapies intended to improve outcomes for patients. Our approach is to fully understand and leverage the mechanisms and properties of our drug candidates to optimize the balance between efficacy and tolerability to best meet the needs of patients with cancer. Each of our pipeline candidates has a unique mechanism of action that can target pathways involved in driving various hematological malignancies and/or solid tumors. Zandelisib (formerly called ME-401) is in multiple ongoing clinical trials evaluating patients with B-cell malignancies intended to support marketing approvals with the FDA and other regulatory authorities globally. Voruciclib, a potent inhibitor of CDK9, is a clinical stage drug candidate being explored in combination with standard therapies for the treatment of hematologic malignances and solid tumors. ME-344, a mitochondrial inhibitor, is a clinical stage drug candidate being evaluated for the treatment of solid tumors. We are committed to pursuing our company mission in a manner that upholds our workplace values of dedication, shared commitment, personal accountability, mutual trust and fiscal discipline. Interested in joining our team of friendly, dedicated, experienced and collaborative professionals? Visit meipharma.com/careers for more details.
MindSupply is a mindfulness meditation app that brings together sleep sounds, guided meditation, relax melodies, artwork, and poetry.
Airway Therapeutics focuses on pulmonary research program of Cincinnati Children’s Hospital Medical Center for further development.
NeuraLace is a technology company with a focus on medical innovations.